Vanguard (RXO) reports 0 shares after internal realignment (13G/A)
Rhea-AI Filing Summary
RXO Inc: The Vanguard Group filed an amendment (Schedule 13G/A, Amendment No. 6) stating it beneficially owns 0 shares of RXO Inc Common Stock, representing 0% of the class. The filing explains an internal realignment on 01/12/2026 that led certain Vanguard subsidiaries and business divisions to report holdings separately.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026, and lists Vanguard’s principal office in Malvern, PA.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership after internal disaggregation.
The Vanguard Group states it beneficially owns 0 shares of RXO common stock and 0% of the class, per the amended Schedule 13G/A. The filing attributes the change to an internal realignment on 01/12/2026 causing separate reporting by subsidiaries and business divisions.
Cash‑flow treatment and any per‑subsidiary holdings are not detailed in the excerpt; subsequent filings by the named subsidiaries may show the redistributed beneficial positions.
Amendment reflects reporting reallocation under SEC Release No. 34-39538.
The filing cites SEC Release No. 34-39538 and explains that certain Vanguard entities will report beneficial ownership separately, and that Vanguard "no longer has, or is deemed to have, beneficial ownership" of securities held by those entities. This is a regulatory-qualification explanation for disaggregation.
Investors should expect separate Schedule 13 filings from the named subsidiaries or divisions rather than aggregate holdings under The Vanguard Group.